Promoting Accountability in
Violation Tracker Parent Company Summary
|Top 10 Primary Offense Types||Penalty Total||Number of Records|
|off-label or unapproved promotion of medical products||$3,000,000,000||1|
|drug or medical equipment safety violation||$750,000,000||1|
|False Claims Act||$197,000,000||2|
|kickbacks and bribery||$20,000,000||1|
|wage and hour violation||$352,773||1|
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty dollar total above may be adjusted to account for the fact that the list of entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Duplicate penalty amounts are marked with an asterisk in the list below.
BLOCK DRUG; GLAXOSMITHKLINE; GLAXOSMITHKLINE PLC; GLAXOSMITHKLINE VACCINES; SB PHARMCO PUERTO RICO; SMITHKLINE BEECHAM
For an overview of this company's accountability track record, read its Corporate Rap Sheet here.
For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.
For a summary of this company's federal contracts, see its page on Fedspending.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
Individual Penalty Records:
|Company||Primary Offense Type||Year||Agency||Penalty Amount|
|GlaxoSmithKline LLC||off-label or unapproved promotion of medical products||2012||FDA||$3,000,000,000|
|SB Pharmco Puerto Rico Inc.||drug or medical equipment safety violation||2010||FDA||$750,000,000|
|GlaxoSmithKline||False Claims Act||2005||DOJ_CIVIL||$150,000,000|
|SmithKline Beecham||False Claims Act||2003||DOJ_CIVIL||$47,000,000|
|GlaxoSmithKline plc||kickbacks and bribery||2016||SEC||$20,000,000|
|Block Drug Company Incorporated||wage and hour violation||2011||WHD||$352,773|
|GlaxoSmithKline LLC||environmental violation||2014||EPA||$317,550|
|GLAXOSMITHKLINE, LLC||environmental violation||2014||EPA||$317,550|
|GlaxoSmithKline Vaccines||environmental violation||2014||EPA||$172,900|
|GLAXOSMITHKLINE VACCINES||environmental violation||2014||EPA||$172,900|